Conde D - Search Results

1

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.

Lincoff AM, Nicholls SJ, Riesmeyer JS, Barter PJ, Brewer HB, Fox KAA, Gibson CM, Granger C, Menon V, Montalescot G, Rader D, Tall AR, McErlean E, Wolski K, Ruotolo G, Vangerow B, Weerakkody G, Goodman SG, Conde D, McGuire DK, Nicolau JC, Leiva-Pons JL, Pesant Y, Li W, Kandath D, Kouz S, Tahirkheli N, Mason D, Nissen SE; ACCELERATE Investigators. Lincoff AM, et al. Among authors: conde d. N Engl J Med. 2017 May 18;376(20):1933-1942. doi: 10.1056/NEJMoa1609581. N Engl J Med. 2017. PMID: 28514624 Free article. Clinical Trial.

2

Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data.

Pope MK, Hall TS, Schirripa V, Radic P, Virdone S, Pieper KS, Le Heuzey JY, Jansky P, Fitzmaurice DA, Cappato R, Atar D, Camm AJ, Kakkar AK; GARFIELD-AF investigators. Pope MK, et al. BMJ. 2021 Oct 27;375:e066450. doi: 10.1136/bmj-2021-066450. BMJ. 2021. PMID: 34706884 Free PMC article.

3

Is vernakalant better or not, compared with other treatments for conversion of acute atrial fibrillation?

Conde D. Conde D. Int J Cardiol. 2013 Oct 30;169(2):95-6. doi: 10.1016/j.ijcard.2013.08.139. Epub 2013 Sep 5. Int J Cardiol. 2013. PMID: 24071384

4

Prognostic utility of ischemic response in functional imaging tests (SPECT or stress echocardiography) in low-risk unstable angina patients.

Trivi M, Ronderos R, Meretta A, Conde D, Avegliano G. Trivi M, et al. Among authors: conde d. Cardiol J. 2015;22(2):160-4. doi: 10.5603/CJ.a2014.0052. Epub 2015 Feb 23. Cardiol J. 2015. PMID: 25704055

5

High-sensitivity troponin is associated with high risk clinical profile and outcome in acute heart failure.

Diez M, Talavera ML, Conde DG, Campos R, Acosta A, Trivi MS. Diez M, et al. Cardiol J. 2016;23(1):78-83. doi: 10.5603/CJ.a2015.0058. Epub 2015 Sep 28. Cardiol J. 2016. PMID: 26412605 Free article.

6

Rivaroxaban in the cardiovascular world: a direct anticoagulant useful to prevent stroke and venous and arterial thromboembolism.

Seoane L, Cortés M, Aris Cancela ME, Furmento J, Baranchuk A, Conde D. Seoane L, et al. Among authors: conde d. Expert Rev Cardiovasc Ther. 2018 Jul;16(7):501-514. doi: 10.1080/14779072.2018.1484281. Epub 2018 Jun 14. Expert Rev Cardiovasc Ther. 2018. PMID: 29862875 Review.

7

Flecainide versus vernakalant for conversion of recent-onset atrial fibrillation.

Conde D, Costabel JP, Caro M, Ferro A, Lambardi F, Corrales Barboza A, Lavalle Cobo A, Trivi M. Conde D, et al. Int J Cardiol. 2013 Oct 3;168(3):2423-5. doi: 10.1016/j.ijcard.2013.02.006. Epub 2013 Mar 19. Int J Cardiol. 2013. PMID: 23518212

8

Fourth-generation troponin I and infarct size in patients with ST-elevation myocardial infarction.

Conde D, Elissamburu P, Lalor N, Rodriguez L. Conde D, et al. Am J Emerg Med. 2014 May;32(5):467. doi: 10.1016/j.ajem.2013.12.040. Epub 2013 Dec 26. Am J Emerg Med. 2014. PMID: 24462397 No abstract available.

9

Adding ivabradine may reduce elevated heart rate in acute patients when β blockers are ineffective.

Trivi M, Forti L, Conde D, Diez M. Trivi M, et al. Among authors: conde d. Am J Emerg Med. 2014 May;32(5):471-2. doi: 10.1016/j.ajem.2014.01.017. Epub 2014 Jan 21. Am J Emerg Med. 2014. PMID: 24581885 No abstract available.

10

Atrial fibrillation: an observational study with outpatients.

Albina G, De Luca J, Conde D, Giniger A. Albina G, et al. Among authors: conde d. Pacing Clin Electrophysiol. 2014 Nov;37(11):1485-91. doi: 10.1111/pace.12462. Epub 2014 Jul 16. Pacing Clin Electrophysiol. 2014. PMID: 25040946

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

250 results

Search Page